Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2010
10/28/2010US20100274005 Bicyclic pyrazole compounds as antibacterial agents
10/28/2010US20100274004 Bicyclic pirazole compounds as antibacterial agents
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273776 Inhibition of alpha-synuclein toxicity
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273653 Use of Compounds Having a Mongalactosydiacylglycerol Syhnthase Inhibitory Activity as Herbicide or Algaecide, Herbicide and Algaecide Compositions
10/28/2010US20100272680 Piperidinyl Cyclic Amido Antiviral Agents
10/28/2010US20100270537 Optoelectronic devices and organic compounds used therein
10/28/2010CA2791947A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010CA2761108A1 Heterocyclic compounds as mek inhibitors
10/28/2010CA2759607A1 Modulators of 5-ht receptors and methods of use thereof
10/28/2010CA2758640A1 3,3'-spiroindolinone derivatives and their use for cancer
10/28/2010CA2754702A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243780A2 Process for the purification of paliperidone
10/27/2010EP2243772A1 Novel P2X7R antagonists and their use
10/27/2010EP2242757A1 Pyrazolopyridines as kinase inhibitors
10/27/2010EP2242756A2 Pyrrolopyrimidines and pyrrolopyridines
10/27/2010EP2242755A1 Pyrrolopyridines as kinase inhibitors
10/27/2010EP1922320B1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/27/2010EP1658282B1 Novel chelating agents and chelates and their use
10/27/2010CN1261823B Metal complex used for oxidation and katalysis system
10/27/2010CN101874019A Preparation of dihydropyrrol derivatives as intermediates
10/27/2010CN101870697A Preparation method of polysubstituted isoquinopyrazole compound
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/27/2010CN101870695A Preparation method of 3-(2-chloroethyl)-6, 7, 8, 9 - tetrahydro-9 - hydroxy - 2 - Methylenetetrahydrofolate - pyrido [1,2-alpha] pyrimidine -4 - ketone
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820824 As labeling reagents for a variety of biological applications
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820816 Using 3-(2-chloroethyl)-2-methyl-9-hydroxy -4H-pyrido(1,2-a)pyrimidin-4-one (CMHP) as chemical intermediate for paliperidone (9-hydroxyrisperidone); catalytic hydrogenation;
10/26/2010US7820691 Indoloquinoline compounds as calcium channel blockers
10/26/2010US7820682 3-{[(3R)-1-(3,5-dimethoxy-4-methylbenzoyl)-5-(2-phenylethyl)-3-pyrrolidinyl]oxy}benzoic acid methyl ester; treatment of urinary system disease; anticarcinogenic agent, antiarthritic agent, treats proliferative disease, inflammation/immune system disease, Sjogren*s syndrome, brain-related disease
10/26/2010US7820666 Tetrahydrotriazolopyrazine derivatives and uses thereof
10/26/2010US7820664 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/26/2010US7820662 IGF-1R enzyme inhibitor; antiproliferative, anticarcinogenic, antiinflammatory agent, antiallergen; psoriasis, asthma, disease and conditions of the immune system and central nervous system; better selectivity or potency, reduced toxicity, or fewer side effects
10/26/2010US7820648 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
10/26/2010US7820143 Water soluble tetrapyrollic photosensitizers for photodynamic therapy
10/26/2010CA2417190C New beta-amyloid inhibitors, processes for preparing them and their use as pharmaceutical compositions
10/26/2010CA2400700C Antiviral azaindole derivatives
10/26/2010CA2372058C Hemisynthetic method of ecteinascidins and new intermediates
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120996A1 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010120991A1 5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
10/21/2010WO2010120987A1 Ring fused, ureidoaryl- and carbamoylaryl-bridged morpholino-pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119285A1 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy
10/21/2010WO2010119284A1 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
10/21/2010WO2010118921A1 Novel p2x7r antagonists and their use
10/21/2010WO2009126514A8 Compounds and compositions as kinase inhibitors
10/21/2010WO2009020470A3 Cgrp receptor antagonists
10/21/2010US20100267954 Process for the purification of paliperidone
10/21/2010US20100267952 Use of novel compound having affinity for amyloid, and process for production of the same
10/21/2010US20100267762 Novel p2x7r antagonists and their use
10/21/2010US20100267761 7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267747 5-(Arylsulfonyl)-Pyrazolopiperidines
10/21/2010US20100267726 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267709 Inhibitors of janus kinases
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267686 Carbacephem beta-lactam antibiotics
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010US20100266507 Luminescent compounds
10/21/2010US20100264382 Fluorine-substituted perylenes for colour filters in lcds
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2757592A1 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
10/21/2010CA2757326A1 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy
10/20/2010EP2241568A1 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device
10/20/2010EP2240970A1 Perylene semiconductors and methods of preparation and use thereof
10/20/2010EP2240483A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/20/2010EP2240482A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
10/20/2010EP2240481A1 (1-azinone) -substituted pyridoindoles as mch antagonists
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240479A1 Novel nitrogen-containing organic compounds that can be used as precursor of a catalytic composition
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240449A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP2029594B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
10/20/2010EP1966199B1 Azaindole-2-carboxamide derivatives
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN1870998B Ccr-2拮抗剂盐 Ccr-2 antagonists salt
10/20/2010CN101868451A Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
10/20/2010CN101863887A Matrine derivative and preparation method thereof
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816526 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
10/19/2010US7816524 Methods of preparing quinolone analogs
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 646